In enriched design trials of THC/CBD spray for MS spasticity, the overall therapeutic gain over placebo was about 1.27 points on a 10-point scale, with carryover effects complicating interpretation.
Read this if you use Sativex for MS spasticity and want to understand the clinical trial evidence.
1.27-point improvement on 10-point spasticity scale over placebo
What the researchers found
This review examined the placebo response in enriched clinical trials of THC/CBD oromucosal spray (Sativex) for MS spasticity. In enriched designs, patients who respond during an initial open-label phase are randomized to continue treatment or switch to placebo.
The authors identified that placebo-allocated patients maintained some improvement after randomization, likely due to carryover effects from the enrichment phase and the pharmacological properties of cannabinoids (slow clearance). The overall therapeutic gain of THC/CBD spray over placebo was estimated at about 1.27 points on a 0-10 spasticity scale, representing a 20.1% improvement from baseline.
The review cautioned that enriched design studies for cannabinoid medications require careful interpretation, as the design itself can underestimate true treatment effects by inflating placebo responses.
Why it matters
Understanding how clinical trial design affects results is essential for accurate drug evaluation. If cannabinoid trials systematically underestimate treatment effects due to enriched designs and carryover, real clinical benefits may be larger than reported.
The numbers in context
Overall therapeutic gain: ~1.27 points on 0-10 NRS. Improvement: ~20.1% from baseline NRS score. 16-week assessment period after enrichment. Enriched design inflated placebo responses.
How the study worked
Review of enriched design clinical trial data for THC/CBD oromucosal spray in MS spasticity. Analyzed placebo effects during enrichment and post-randomization phases, examining carryover effects and other factors maintaining efficacy in placebo-allocated patients.
What this study cannot tell us
Focus on a single medication (THC/CBD spray) and one condition (MS spasticity). The estimated therapeutic gain is an aggregate that may not apply to all patients. The review discusses potential biases but cannot fully quantify them.
How to read the evidence
Review of enriched design trial data. Important methodological contribution but based on a single treatment and condition.
When this study was published
Published in 2015. Additional Sativex trials have been completed since.
The bigger picture
Clinical trials of cannabinoid medications face unique methodological challenges. Slow drug clearance, strong placebo effects for symptom-based outcomes, and the enriched design all make it difficult to capture true treatment effects, potentially leading to underestimation of efficacy.
Questions still open
- Should cannabinoid trials use different design approaches to avoid carryover effects? Would non-enriched designs show larger treatment effects? How do placebo effects in cannabinoid trials compare to other neurological medications?
Common questions
Does THC/CBD spray work for MS spasticity?
What is an enriched clinical trial design?
Read the original research
Placebo effects in a multiple sclerosis spasticity enriched clinical trial with the oromucosal cannabinoid spray (THC/CBD): dimension and possible causes.
CNS neuroscience & therapeutics, 21(3), 215-21
Citation
Di Marzo, Vincenzo; Centonze, Diego. (2015). Placebo effects in a multiple sclerosis spasticity enriched clinical trial with the oromucosal cannabinoid spray (THC/CBD): dimension and possible causes.. CNS neuroscience & therapeutics, 21(3), 215-21. https://doi.org/10.1111/cns.12358
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk